Effect of mitogenic or regenerative cell proliferation on lacz mutant frequency in the liver of Muta(TM)Mice treated with 5,9-dimethyldibenzo[c,g]carbazole

Carcinogenesis

Volumn 20, Issue 7, 1999, Pages 1357-1362

  Tombolan, Françoise ^a,b   Renault, Dominique ^a   Brault, Dominique ^a   Guffroy, Magali ^a   Périn, François ^c   Thybaud, Véronique ^a  

^a SANOFI   (France)

^b CNRS   (France)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,9 DIMETHYLDIBENZO[C,G]CARBAZOLE; BETA GALACTOSIDASE; BROXURIDINE; CARBAZOLE DERIVATIVE; CARBON TETRACHLORIDE; CARCINOGEN; CYTOTOXIC AGENT; MITOGENIC AGENT; PHENOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; LABELING INDEX; LIVER CARCINOGENESIS; MALE; MITOGENESIS; MOUSE; MOUSE MUTANT; MUTAGENICITY; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARBAZOLES; CARBON TETRACHLORIDE; CELL DIVISION; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; LAC OPERON; LIVER; LIVER REGENERATION; MALE; MICE; MICE, TRANSGENIC; MITOGENS; MUTAGENICITY TESTS; MUTATION; ORGAN SIZE; PHENOBARBITAL;

EID: 0032808216     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.7.1357     Document Type: Article

References (44)

1. Cayama, E., Tsuda, H., Sarma, D.S.R. and Farber, E. (1978) Initiation of chemical carcinogenesis requires cell proliferation. Nature (Lond.), 275, 60-62.
2. Pound, A.W. and McGuire, L.J. (1978) Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rats. Br. J. Cancer, 37, 585-594.
3. Farber, E. (1982) Sequential events in chemical carcinogenesis. In Becker, F.F. (ed.) Cancer: A Comprehensive Treatise. 2nd edn. Plenum Press, New York, Vol. 1, pp 485-506.
4. McGhee, J.O'D. and Patrick, R.S. (1969) The synthesis of sulphated mucopolysaccharide in mouse liver following carbon tetrachloride injury. I. Autoradiographic studies. Br. J. Exp. Pathol., 50, 521-526.
5. McGhee, J.O'D. (1980) The healing response in liver. In Varieties of Healing and their Clinical Implications. Folia Traumatologica, Geigy, pp 13-15.
6. Argyris, T.S. and Magnus, D.R. (1968) The stimulation of liver growth and demethylase activity following phenobarbital treatment. Dev. Biol., 17, 187-201.
7. Schulte-Hermann, R. (1974) Induction of liver growth by xenobiotic compounds and other stimuli. Crit. Rev. Toxicol., 3, 97-158.
8. Gossen, J.A., DeLeeuw, W.J.F., Tan, C.H.T., Zwarthoff, E.C., Berends, F., Lohman, P.H.M., Knook, D.L. and Vijg, J. (1989) Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl Acad. Sci. USA, 86, 7971-7975.
9. - plasmids. Nucleic Acids Res., 20, 3254.
10. Valéro, D., Périn, F. and Zajdela, F. (1983) Binding of 5,9-dimethyldibenzo[c,g]carbazole, a potent hepatocarcinogen, to mouse hepatic cytosolic proteins, Carcinogenesis, 4, 1333-1340.
11. Valéro, D., Périn, F., Plessis, M.J. and Zajdela, F. (1985) Sexual differences in the expression of gamma-glutamyl transpeptidase during 5,9-dimethyldibenzo[c,g]carbazole induced hepatocarcinogenesis in mouse, Cancer Lett., 27, 181-187.
12. Tombolan, F., Renault, D., Brault, D., Guffroy, M., Périn-Roussel, O., Périn, F. and Thybaud, V. (1999) Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of Muta™Mice treated with 5,9-dimethyl-dibenzo[c,g]carbazole. Carcinogenesis, 20, 125-132.
13. Renault, D., Tombolan, F., Brault, D., Périn, F. and Thybaud, V. (1998) Comparative mutagenicity of 7H-dibenzo[c,g]carbazole and two derivatives in Muta™Mouse liver and skin. Mutat. Res., 417, 129-140.
14. Stratagene (1992) Big Blue Transgenic Mouse Mutagenesis Assay Manual. Stratagene, La Jolla, CA.
15. Renault, D., Brault, D. and Thybaud, V. (1997) Effect of ethylnitrosourea and methyl methanesulfonate on mutation frequency in Muta™Mouse germ cells (seminiferous tubule cells and epididymis spermatozoa). Mutat. Res., 388, 145-153.
16. Dean, S.W. and Myrh, B. (1994) Measurement of gene mutations in vivo using Muta™Mouse and positive selection for lacZ-phage. Mutagenesis, 9, 183-185.
17. Callahan, J.D. and Short, J.M. (1995) Transgenic λ/lacI mutagenicity assay: statistical determination of sample size. Mutat. Res., 327, 201-208.
18. Mirsalis, J.C., Hamer, MD., O'Loughlin, K.G., Winegar, R.A. and Short, J.M. (1993) Effects of nongenotoxic carcinogens on hepatic mutations in lacI transgenic mice. Environ. Mol. Mutagen., 21 (Suppl. 22), 48.
19. Gunz, D., Shepard, S.E. and Lutz, W.K. (1993) Can nongenotoxic carcinogens be detected with the lacI transgenic mouse mutation assay? Environ. Mol. Mutagen., 21, 209-211.
20. Okada, N., Honda, A., Kawabata, M. and Yajima, N. (1997) Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine. Mutagenesis, 12, 179-184.
21. McCann, J., Choi, E., Yamasaki, E. and Ames, B.N. (1975) Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl Acad. Sci. USA. 72, 5135-5139.
22. Dean, B.J. and Hodson-Walker, G. (1979) An in vitro chromosome assay using cultured rat liver cells. Mutat. Res., 64, 329-337.
23. Whysner, J., Ross, P.M. and Williams, G.M. (1996) Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation and tumor promotion. Pharmacol. Ther., 71, 153-191.
24. Eschenbrenner, A.B. and Miller, E. (1944) Studies on hepatomas. I. Size and spacing of multiple doses in the induction of carbon tetrachloride hepatomas. J. Natl Cancer Inst., 4, 385-388.
25. Thorpe, E. and Walker, A.I.T. (1973) The toxicology of dieldrin (HEOD*). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, b-BHC and g-BHC. Food Cosmet. Toxicol., 11, 433-442.
26. Butterworth, B.E., Conolly, R.B. and Morgan, K.T. (1995) A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett., 93, 129-146.
27. Lefevre, P.A., Tinwell, H., Galloway, S.M., Hill, R., Mackay, J.M., Elcombe, C.R., Foster, J., Randall, V., Callander, R.D. and Ashby, J. (1994) Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using MutaMouse and Big Blue transgenic mice. Hum. Exp. Toxicol., 13, 764-775.
28. Kohler, S.W., Provost, G.S., Kretz, P.L., Dycaico, M.J., Sorge, J.A. and Short, J.M. (1990) Development of a short-term in vivo mutagenesis assay: the effects of methylation on the recovery of a lambda phage shuttle vector from transgenic mice. Nucleic Acids Res., 18, 3007-3013.
29. Butterworth, B.E., Templin, M.V., Constan, A.A., Sprankle, C.S., Wong, B.A., Pluta, L.J., Everitt, J.I. and Recio, L. (1998) Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice. Environ. Mol. Mutagen., 31, 248-256.
30. Bursch, W., Lauer, B., Timmermann-Trosenier, I., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-458.
31. Schulte-Hermann, R., Timmermann-Trosenier, I., Barthel, G. and Bursch, W. (1990) DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res., 50, 5127-5135.
32. Gonzales, A.J., Christensen, J.G., Preston, R.J., Goldsworthy, T.L., Tlsty, T.D. and Fox, T.R. (1998) Attenuation of G\ checkpoint function by the nongenotoxic carcinogen phenobarbital. Carcinogenesis, 19, 1173-1183.
33. Mirsalis, J.C., Provost, S., MacGregor, J., Matthews, C., Hamner, R., Schindler, J. and Short, J. (1992) Induction of hepatic mutations in lacI transgenic mice exposed to dimethylnitrosamine or methylmethanesulfonate. Toxicologist, 12, 53.
34. Hayward, J.J., Shane, B.S., Tindall, K.R. and Cunningham, M.L. (1995) Differential in vivo mutagenicity of the carcinogen/noncarcinogen pair 2,4-and 2,6-diaminotoluene. Carcinogenesis, 16, 2429-2433.
35. Davies, R., Oreffo, V.I.C., Martin, E.A., Festing, M.F.W., White, I.N.H., Smith, L.L. and Styles, J.A. (1997) Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats. Cancer Res., 57, 1288-1293.
36. Lefevre, P.A., Tinwell, H. and Ashby, J. (1997) Mutagenicity of the potent rat hepatocarcinogen 6-BT to the liver of the transgenic (lacI) rats: consideration of a reduced mutation assay protocol. Mutagenesis, 12, 45-47.
37. Krebs, O., Schäfer, B., Wolff, T., Oesterle, D., Deml, E., Sund, M. and Favor, J. (1998) The DNA damaging drug cyproterone acetate causes gene mutations and induces glutathione-S-transferase P in the liver of female Big Blue® transgenic rats. Carcinogenesis, 19, 241-245.
38. Shane, B.S., Wood, V.J., Cunningham, M.L. and Tindall, K.R. (1995) Effect of partial hepatectomy on the mutant frequency of lacI in Big Blue® mice treated with N-ethyl-N-nitrosourea. Environ. Mol. Mutagen., 25 (Suppl. 25), 47.
39. Wang, L.Y., Chen, C.J., Zhang, Y.J., Tsai, W.Y., Lee, P.H., Feitelson, M.A., Lee, C.S. and Santella, R.M. (1998) 4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am. J. Epidemiol., 147, 315-323.
40. Hillan, K.J., Logan, M.C., Ferrier, R.K., Bird, G.L., Bennett, G.L., McKay, I.C. and MacSween, R.N. (1996) Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis. J. Hepatol., 24, 385-390.
41. Masuhara, M., Yasunaga, M., Tanigawa, K., Tamura, F., Yamashita, S., Sakaida, I. and Okita, K. (1996) Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatology, 24, 323-329.
42. Kawakita, N., Seki, S., Sakaguchi, H., Yanai, A., Kuroki, T., Mizoguchi, Y., Kobayashi, K. and Monna, T. (1992) Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/ cyclin in embedded tissues from various liver diseases fixed in formaldehyde. Am. J. Pathol., 140, 513-520.
43. Harada, H., Imamura, H., Miyagawa, S. and Kawasaki, S. (1997) Fate of human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study. Hepatology, 26, 1162-1170.
44. Hrusovsky, S., Jouvenot, M., Vuillermoz, C., Heyd, B., Chabod, P., Mantion, G., Miguet, J.P. and Adessi, G.L. (1994) Regeneration of transplanted human liver: gene expression at the time of graft implantation. C.R. Seances Soc. Biol. Fil., 188, 245-258.